The effect of activation of angiogenesis pathways independent of VEGF in renal cell carcinoma on resistance to VEGF-targeted antiangiogenic therapy.

被引：0
|
作者：
Han, Kyung Seok [1 ]
Gust, Kilian [1 ]
Awrey, Shannon [1 ]
Raven, Peter A. [1 ]
Li, Estelle [1 ]
Fazli, Ladan [1 ]
Gleave, Martin E. [1 ]
So, Alan I. [1 ]
机构：
[1] Vancouver Prostate Ctr, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.409
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
409
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma
    Han, Kyung Seok
    Raven, Peter A.
    Frees, Sebastian
    Gust, Kilian
    Fazli, Ladan
    Ettinger, Susan
    Hong, Sung Joon
    Kollmannsberger, Cristian
    Gleave, Martin E.
    So, Alan I.
    NEOPLASIA, 2015, 17 (11): : 805 - 816
  • [2] VEGF-targeted therapy in renal cell carcinoma: Active drugs and active choices
    Rini B.I.
    Current Oncology Reports, 2006, 8 (2) : 85 - 89
  • [3] Everolimus in patients with metastatic renal cell carcinoma refractory to VEGF-targeted therapy: REACT subgroup analysis of prior therapy.
    Larkin, James M. G.
    Blank, Christian U.
    Bono, Petri
    Gogov, Svetozar
    Panneerselvam, Ashok
    Garay, Carlos A.
    Gruenwald, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [4] Evaluating the effect of tobacco on prostate cancer outcomes with VEGF-targeted therapy.
    Harzstark, Andrea Lynne
    Halabi, Susan
    Kelly, William Kevin
    Morris, Michael J.
    Febbo, Phillip G.
    Small, Eric Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [5] A systematic review of predictive and prognostic biomarkers for VEGF-targeted therapy in renal cell carcinoma
    Funakoshi, Tomohiro
    Lee, Chung-Han
    Hsieh, James J.
    CANCER TREATMENT REVIEWS, 2014, 40 (04) : 533 - 547
  • [6] The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients
    Al-Marrawi, Mhd Y.
    Rini, Brian I.
    Harshman, Lauren C.
    Bjarnason, Georg
    Wood, Lori
    Vaishampayan, Ulka
    MacKenzie, Mary
    Knox, Jennifer J.
    Agarwal, Neeraj
    Al-Harbi, Hulayel
    Kollmannsberger, Christian
    Tan, Min-Han
    Rha, Sun Young
    Donskov, Frede N.
    North, Scott
    Choueiri, Toni K.
    Heng, Daniel Y.
    TARGETED ONCOLOGY, 2013, 8 (03) : 203 - 209
  • [7] Failure of initial VEGF-targeted therapy in metastatic renal cell carcinoma (mRCC): What next?
    Vickers, M. M.
    Choueiri, T. K.
    Zama, I.
    Cheng, T.
    North, S.
    Knox, J. J.
    Kollmannsberger, C.
    McDermott, D. F.
    Rini, B. I.
    Heng, D. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Predictive and Prognostic Clinicopathologic Factors of Metastatic Renal Cell Carcinoma Treated with VEGF-Targeted Therapy
    Park, J. Y.
    Lee, J-L
    Ro, J. Y.
    Cho, Y. M.
    LABORATORY INVESTIGATION, 2013, 93 : 239A - 239A
  • [9] The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients
    Mhd Y. Al-Marrawi
    Brian I. Rini
    Lauren C. Harshman
    Georg Bjarnason
    Lori Wood
    Ulka Vaishampayan
    Mary MacKenzie
    Jennifer J. Knox
    Neeraj Agarwal
    Hulayel Al-Harbi
    Christian Kollmannsberger
    Min-Han Tan
    Sun Young Rha
    Frede N. Donskov
    Scott North
    Toni K. Choueiri
    Daniel Y. Heng
    Targeted Oncology, 2013, 8 : 203 - 209
  • [10] Predictive and Prognostic Clinicopathologic Factors of Metastatic Renal Cell Carcinoma Treated with VEGF-Targeted Therapy
    Park, J. Y.
    Lee, J-L
    Ro, J. Y.
    Cho, Y. M.
    MODERN PATHOLOGY, 2013, 26 : 239A - 239A
12345